PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PAVmed Inc. Series Z Warrant (PAVMZ)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

CUSIP70387R122
SectorHealthcare
IndustryMedical Devices

Highlights

Revenue (TTM)$2.45M
EBITDA (TTM)-$65.86M
Year Range$0.02 - $0.27

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


PAVmed Inc. Series Z Warrant

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in PAVmed Inc. Series Z Warrant, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2024FebruaryMarchAprilMay
-97.00%
98.57%
PAVMZ (PAVmed Inc. Series Z Warrant)
Benchmark (^GSPC)

S&P 500

Returns By Period

PAVmed Inc. Series Z Warrant had a return of -72.73% year-to-date (YTD) and -72.73% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-72.73%10.00%
1 month-29.08%2.41%
6 months-53.85%16.70%
1 year-72.73%26.85%
5 years (annualized)-41.90%12.81%
10 years (annualized)N/A10.84%

Monthly Returns

The table below presents the monthly returns of PAVMZ, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-44.27%-21.04%-27.48%20.80%-72.73%
2023-4.55%-4.76%-25.00%-23.67%-3.93%45.45%-25.00%-15.83%-0.89%-2.50%-28.38%57.37%-50.00%
2022-42.50%8.70%-18.00%-16.13%-8.39%-20.63%27.98%-4.69%-27.86%29.48%-49.10%-24.14%-86.25%
2021-5.30%144.58%4.43%8.13%20.92%31.08%12.06%2.30%24.28%-41.97%-43.89%-28.89%36.75%
202065.21%82.24%-20.56%17.27%-9.72%4.66%-5.82%-2.06%-12.28%-6.40%23.08%21.88%201.08%
20197.81%-7.25%21.16%14.78%-14.61%10.53%-9.52%-13.16%-3.03%-6.25%3.33%25.35%21.44%
2018-45.00%9.09%-43.33%73.53%-20.34%-0.00%-19.15%-17.71%2.33%-68.00%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PAVMZ is 42, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of PAVMZ is 4242
PAVMZ (PAVmed Inc. Series Z Warrant)
The Sharpe Ratio Rank of PAVMZ is 3434Sharpe Ratio Rank
The Sortino Ratio Rank of PAVMZ is 8282Sortino Ratio Rank
The Omega Ratio Rank of PAVMZ is 7777Omega Ratio Rank
The Calmar Ratio Rank of PAVMZ is 55Calmar Ratio Rank
The Martin Ratio Rank of PAVMZ is 1212Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for PAVmed Inc. Series Z Warrant (PAVMZ) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


PAVMZ
Sharpe ratio
The chart of Sharpe ratio for PAVMZ, currently valued at -0.22, compared to the broader market-2.00-1.000.001.002.003.004.00-0.22
Sortino ratio
The chart of Sortino ratio for PAVMZ, currently valued at 2.23, compared to the broader market-4.00-2.000.002.004.006.002.23
Omega ratio
The chart of Omega ratio for PAVMZ, currently valued at 1.26, compared to the broader market0.501.001.502.001.26
Calmar ratio
The chart of Calmar ratio for PAVMZ, currently valued at -0.83, compared to the broader market0.002.004.006.00-0.83
Martin ratio
The chart of Martin ratio for PAVMZ, currently valued at -1.24, compared to the broader market-10.000.0010.0020.0030.00-1.24
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.35, compared to the broader market-2.00-1.000.001.002.003.004.002.35
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.33, compared to the broader market-4.00-2.000.002.004.006.003.33
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.90, compared to the broader market0.002.004.006.001.90
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.02, compared to the broader market-10.000.0010.0020.0030.009.02

Sharpe Ratio

The current PAVmed Inc. Series Z Warrant Sharpe ratio is -0.22. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of PAVmed Inc. Series Z Warrant with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00December2024FebruaryMarchAprilMay
-0.22
2.35
PAVMZ (PAVmed Inc. Series Z Warrant)
Benchmark (^GSPC)

Dividends

Dividend History


PAVmed Inc. Series Z Warrant doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-99.61%
-0.15%
PAVMZ (PAVmed Inc. Series Z Warrant)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the PAVmed Inc. Series Z Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the PAVmed Inc. Series Z Warrant was 99.74%, occurring on Apr 25, 2024. The portfolio has not yet recovered.

The current PAVmed Inc. Series Z Warrant drawdown is 99.61%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.74%Sep 24, 2021560Apr 25, 2024
-80%Apr 13, 2018116Dec 24, 2018241Feb 21, 2020357
-63.91%Feb 25, 202013Mar 12, 2020233Feb 12, 2021246
-43.16%Feb 23, 202110Mar 8, 202120Apr 6, 202130
-41.54%Apr 7, 202128May 14, 202115Jun 7, 202143

Volatility

Volatility Chart

The current PAVmed Inc. Series Z Warrant volatility is 158.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%50.00%100.00%150.00%December2024FebruaryMarchAprilMay
158.46%
3.35%
PAVMZ (PAVmed Inc. Series Z Warrant)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of PAVmed Inc. Series Z Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items